Oncolytics Biotech, Inc. (ONCY)
0.631
-0.01
(-1.59%)
USD |
NASDAQ |
Oct 02, 16:00
0.6246
-0.01
(-1.01%)
After-Hours: 20:00
Oncolytics Biotech Net Income (Quarterly) : -9.442M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.442M |
| March 31, 2026 | -9.243M |
| December 31, 2025 | -1.507M |
| September 30, 2025 | -9.878M |
| June 30, 2025 | -5.277M |
| March 31, 2025 | -4.660M |
| December 31, 2024 | 0.899M |
| September 30, 2024 | -6.872M |
| June 30, 2024 | -5.207M |
| March 31, 2024 | -4.952M |
| December 31, 2023 | -2.899M |
| September 30, 2023 | -7.400M |
| June 30, 2023 | -5.540M |
| March 31, 2023 | -4.759M |
| December 31, 2022 | -6.301M |
| September 30, 2022 | -3.374M |
| June 30, 2022 | -3.99M |
| March 31, 2022 | -5.352M |
| December 31, 2021 | -6.149M |
| September 30, 2021 | -3.866M |
| June 30, 2021 | -5.902M |
| March 31, 2021 | -5.082M |
| December 31, 2020 | -7.159M |
| September 30, 2020 | -5.064M |
| June 30, 2020 | -4.928M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2971M |
| December 31, 2019 | -14.70M |
| September 30, 2019 | -2.672M |
| June 30, 2019 | -3.927M |
| March 31, 2019 | -3.715M |
| December 31, 2018 | -3.649M |
| September 30, 2018 | -2.552M |
| June 30, 2018 | -3.262M |
| March 31, 2018 | -3.693M |
| December 31, 2017 | -3.733M |
| September 30, 2017 | -2.397M |
| June 30, 2017 | -3.234M |
| March 31, 2017 | -2.658M |
| December 31, 2016 | -3.904M |
| September 30, 2016 | -2.555M |
| June 30, 2016 | -2.002M |
| March 31, 2016 | -2.924M |
| December 31, 2015 | -2.619M |
| September 30, 2015 | -2.158M |
| June 30, 2015 | -3.131M |
| March 31, 2015 | -2.862M |
| December 31, 2014 | -3.328M |
| September 30, 2014 | -4.260M |
| June 30, 2014 | -4.326M |
| March 31, 2014 | -4.973M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
| Vicapsys Life Sciences, Inc. | -0.1046M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 9.442M |
| EPS Diluted (Quarterly) | -0.0788 |
| Enterprise Value | 74.98M |
| Earnings Yield | -43.19% |
| Normalized Earnings Yield | -43.25 |